SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Qiang Gao, Ying–Jun Zhao, Xiao–Ying Wang, Wei–Jie Guo, Song Gao, Lin Wei, Jie–Yi Shi, Guo–Ming Shi, Zhi–Chao Wang, Yuan–Nv Zhang, Ying–Hong Shi, Jie Ding, Zhen–Bin Ding, Ai–Wu Ke, Zhi Dai, Fei–Zhen Wu, Hui Wang, Zhao–Ping Qiu, Zhi–Ao Chen, Zhen–Feng Zhang, Shuang–Jian Qiu, Jian Zhou, Xiang–Huo He, Jia Fan, Activating Mutations in PTPN3 Promote Cholangiocarcinoma Cell Proliferation and Migration and Are Associated With Tumor Recurrence in Patients, Gastroenterology, 2014, 146, 5, 1397

    CrossRef

  2. 2
    Milind Javle, Asif Rashid, Chaitanya Churi, Siddhartha Kar, Mingxin Zuo, Agda Karina Eterovic, Graciela M. Nogueras-Gonzalez, Filip Janku, Rachna T. Shroff, Thomas A. Aloia, Jean-Nicholas Vauthey, Steven Curley, Gordon Mills, Ivan Roa, Molecular characterization of gallbladder cancer using somatic mutation profiling, Human Pathology, 2014, 45, 4, 701

    CrossRef

  3. 3
    Anthony T. Ruys, Bas Groot Koerkamp, Jimme K. Wiggers, Heinz-Josef Klümpen, Fiebo J. ten Kate, Thomas M. van Gulik, Prognostic Biomarkers in Patients with Resected Cholangiocarcinoma: A Systematic Review and Meta-analysis, Annals of Surgical Oncology, 2014, 21, 2, 487

    CrossRef

  4. 4
    Shinsuke Nakashima, Shogo Kobayashi, Daisuke Sakai, Akira Tomokuni, Yoshito Tomimaru, Naoki Hama, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Nariaki Matsuura, Yuichiro Doki, Masaki Mori, Hiroaki Nagano, Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer, Journal of Surgical Oncology, 2014, 110, 6
  5. 5
    Sumalee Obchoei, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, Watchara Kasinrerk, Qizhi Yao, Changyi Chen, Sopit Wongkham, Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway, Tumor Biology, 2014,

    CrossRef

  6. 6
    Mumtaz Ansari, Ruhi Dixit, Vijay Shukla, Cancer Biomarkers, 2014,

    CrossRef

  7. 7
    Ming-Huang Chen, Kun-Ju Lin, Wu-Lung R. Yang, Ya-Wen Kao, Tsung-Wen Chen, Shu-Chaou Chao, Peter Mu-Hsin Chang, Chun-Yu Liu, Cheng-Hwai Tzeng, Yee Chao, Ming-Han Chen, Chun-Nan Yeh, Chi-Ying F. Huang, Gene expression-based chemical genomics identifies heat-shock protein 90 inhibitors as potential therapeutic drugs in cholangiocarcinoma, Cancer, 2013, 119, 2
  8. 8
    Guo-shun Shu, Fang Lv, Zhu-lin Yang, Xiong-ying Miao, Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances, International Journal of Clinical Oncology, 2013, 18, 4, 641

    CrossRef

  9. 9
    D Sia, V Tovar, A Moeini, J M Llovet, Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies, Oncogene, 2013, 32, 41, 4861

    CrossRef

  10. 10
    Jesse S. Voss, Leonard M. Holtegaard, Sarah E. Kerr, Emily G. Barr Fritcher, Lewis R. Roberts, Gregory J. Gores, Jun Zhang, W. Edward Highsmith, Kevin C. Halling, Benjamin R. Kipp, Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions, Human Pathology, 2013, 44, 7, 1216

    CrossRef

  11. 11
    Carmen Berasain, Matias A. Ávila, Platelet-derived growth factor D: A new player in the complex cross-talk between cholangiocarcinoma cells and cancer-associated fibroblasts, Hepatology, 2013, 58, 3
  12. 12
    Massimiliano Cadamuro, Giorgia Nardo, Stefano Indraccolo, Luigi Dall'Olmo, Luisa Sambado, Lidia Moserle, Irene Franceschet, Michele Colledan, Marco Massani, Tommaso Stecca, Nicolò Bassi, Stuart Morton, Carlo Spirli, Romina Fiorotto, Luca Fabris, Mario Strazzabosco, Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma, Hepatology, 2013, 58, 3
  13. 13
    Kshitij Srivastava, Anvesha Srivastava, Balraj Mittal, Potential biomarkers in gallbladder cancer: present status and future directions, Biomarkers, 2013, 18, 1, 1

    CrossRef

  14. 14
    Daisaku Yamada, Shogo Kobayashi, Hiroshi Wada, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Hideshi Ishii, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial–mesenchymal transition and chemoresistance in biliary tract cancer, European Journal of Cancer, 2013, 49, 7, 1725

    CrossRef

  15. 15
    Adriana Romiti, Chiara D’Antonio, Angelo Zullo, Ida Sarcina, Roberta Di Rocco, Viola Barucca, Valeria Durante, Paolo Marchetti, Chemotherapy for the Biliary Tract Cancers: Moving Toward Improved Survival Time, Journal of Gastrointestinal Cancer, 2012, 43, 3, 396

    CrossRef

  16. 16
    Teijiro Hirashita, Yukio Iwashita, Masayuki Ohta, Yoko Komori, Hidetoshi Eguchi, Kazuhiro Yada, Seigo Kitano, Expression of Matrix Metalloproteinase-7 is an Unfavorable Prognostic Factor in Intrahepatic Cholangiocarcinoma, Journal of Gastrointestinal Surgery, 2012, 16, 4, 842

    CrossRef

  17. 17
    Usha Dutta, Gallbladder cancer: Can newer insights improve the outcome?, Journal of Gastroenterology and Hepatology, 2012, 27, 4
  18. 18
    Joshua Peck, Lai Wei, Mark Zalupski, Bert O’Neil, Miguel Villalona Calero, Tanios Bekaii-Saab, HER2/neu May Not Be an Interesting Target in Biliary Cancers: Results of an Early Phase II Study with Lapatinib, Oncology, 2012, 82, 3, 175

    CrossRef

  19. 19
    E. Boucher, Traitement médical des cholangiocarcinomes: de l’adjuvant au métastatique, du nouveau ?, Oncologie, 2012, 14, 3, 150

    CrossRef

  20. 20
    Alphonse E. Sirica, The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma, Nature Reviews Gastroenterology & Hepatology, 2011, 9, 1, 44

    CrossRef